Specific features of neurological complications developing in patients with type 2 diabetes mellitus and metabolic syndrome: Possibility for correction and prevention

被引:0
作者
Shishkova, V. N. [1 ]
机构
[1] Moscow Healthcare Dept, Ctr Speech Pathol & Neurorehabil, Moscow, Russia
关键词
type 2 diabetes mellitus; metabolic syndrome; oxidative stress; mexidol; PERIPHERAL NEUROPATHY; INSULIN-RESISTANCE; NATURAL-HISTORY; RISK; HYPERINSULINEMIA; HYPERTENSION; POPULATION; OBESITY;
D O I
10.17116/terarkh2015871109-114
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The prevalence of type 2 diabetes mellitus (DM) and preceding metabolic disturbances has reached epidemic proportions. Oxidative stress plays a significant role in the development of micro- and macrovascular complications in patients with DM. The accumulation of free radicals is responsible for the development of systemic and vascular inflammation, endothelial dysfunction, and hypercoagulable and ischemic states. Since vascular and nervous system damages do not level off even under adequate glycemic control, there is a need for complex pathogenetic treatment strategies. Antioxidant therapy using mexidol is one of the compulsory components of combination therapy for complications of DM.
引用
收藏
页码:109 / 114
页数:8
相关论文
共 16 条
  • [1] [Anonymous], 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003804
  • [2] BRANDS MW, 1995, J NUTR, V125, pS1725, DOI 10.1093/jn/125.suppl_6.1725S
  • [3] INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE
    DEFRONZO, RA
    FERRANNINI, E
    [J]. DIABETES CARE, 1991, 14 (03) : 173 - 194
  • [4] Does insulin dysfunction play a role in Alzheimer's disease?
    Gasparini, L
    Netzer, WJ
    Greengard, P
    Xu, HX
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (06) : 288 - 293
  • [5] GLUCOSE-INTOLERANCE, HYPERINSULINEMIA AND COGNITIVE FUNCTION IN A GENERAL-POPULATION OF ELDERLY MEN
    KALMIJN, S
    FESKENS, EJM
    LAUNER, LJ
    STIJNEN, T
    KROMHOUT, D
    [J]. DIABETOLOGIA, 1995, 38 (09) : 1096 - 1102
  • [6] Insulin resistance and atherosclerosis
    Nigro, J
    Osman, N
    Dart, AM
    Little, PJ
    [J]. ENDOCRINE REVIEWS, 2006, 27 (03) : 242 - 259
  • [7] Diabetes mellitus and the risk of dementia - The Rotterdam Study
    Ott, A
    Stolk, RP
    van Harskamp, F
    Pols, HAP
    Hofman, A
    Breteler, MMB
    [J]. NEUROLOGY, 1999, 53 (09) : 1937 - 1942
  • [8] NATURAL-HISTORY OF PERIPHERAL NEUROPATHY IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    PARTANEN, J
    NISKANEN, L
    LEHTINEN, J
    MERVAALA, E
    SIITONEN, O
    UUSITUPA, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (02) : 89 - 94
  • [9] Diabetes mellitus and dementia
    Pasquier, F.
    Boulogne, A.
    Leys, D.
    Fontaine, P.
    [J]. DIABETES & METABOLISM, 2006, 32 (05) : 403 - 414
  • [10] Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: An endocrine society clinical practice guideline
    Rosenzweig, James L.
    Ferrannini, Ele
    Grundy, Scott M.
    Haffner, Steven M.
    Heine, Robert J.
    Horton, Edward S.
    Kawamori, Ryuzo
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (10) : 3671 - 3689